CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Prestige Consumer Healthcare Inc.  (PBH)
Other Ticker:  
 
 

PBH's Net Income Growth by Quarter and Year

Prestige Consumer Healthcare's Net Income results by quarter and year




PBH Net Income (in millions $) FY 2019 FY 2018 FY 2017 FY 2016
IV Quarter March - -146.65 11.09 13.94
III Quarter December - 372.43 31.64 28.00
II Quarter September 74.36 80.03 32.20 31.80
I Quarter June 80.93 33.76 -5.53 26.17
FY   155.29 339.57 69.40 99.91



PBH Net Income second quarter 2019 Y/Y Growth Comment
Prestige Consumer Healthcare Inc. reported decrease in Net Income in the second quarter by -7.08% to $ 74.36 millions, from the same quarter in 2018.
The decrease in the second quarter Prestige Consumer Healthcare Inc.'s Net Income compares unfavorably to the Company's average Net Income increase of 14.81%.

Looking into second quarter results within Major Pharmaceutical Preparations industry 6 other companies have achieved higher Net Income growth. While Prestige Consumer Healthcare Inc.' s Net Income decline of -7.08% ranks overall at the positon no. 709 in the second quarter.




PBH Net Income ( Y/Y Growth %) 2019
2018 2017 2016
IV Quarter March - - -20.44 % -41.35 %
III Quarter December - 1077.09 % 13 % 31.52 %
II Quarter September -7.08 % 148.54 % 1.26 % 93.2 %
I Quarter June 139.72 % - - 56.43 %
FY   - 389.29 % -30.54 % -

Financial Statements
Prestige Consumer Healthcare's second quarter 2019 Net Income $ 0.00 millions PBH's Income Statement
Prestige Consumer Healthcare's second quarter 2018 Net Income $ 0.00 millions Quarterly PBH's Income Statement
New: More PBH's historic Net Income Growth >>


PBH Net Income (Quarter on Quarter Growth %)

2019
2018 2017 2016
IV Quarter March - - -64.95 % -50.21 %
III Quarter December - 365.36 % -1.74 % -11.95 %
II Quarter September -8.12 % 137.06 % - 21.51 %
I Quarter June - 204.42 % - 10.1 %
FY (Year on Year)   - 389.29 % -30.54 % -




Net Income second quarter 2019 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #7
Healthcare Sector #41
Overall #709

Net Income Y/Y Growth Statistics
High Average Low
217.74 % 14.81 % -31.73 %
(Dec 31 2017)   (June 30. 2016)
Net Income second quarter 2019 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #7
Healthcare Sector #41
Overall #709
Net Income Y/Y Growth Statistics
High Average Low
217.74 % 14.81 % -31.73 %
(Dec 31 2017)   (June 30. 2016)

Net Income by Quarter for the Fiscal Years 2016, 2017, 2018, 2019

Prestige Consumer Healthcare's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
411.21 % 51.64 % -90.45 %
(Mar 31 2014)  


PBH's II. Quarter Q/Q Net Income Comment
In the II. Quarter 2019 Prestige Consumer Healthcare Inc. realized drop in Net Income from the previous quarter by -8.12% to $ 74.36 millions, from $ 80.93 millions declared in the previous reporting period.

Although periodic influence normally fuel II. Quarter 2019 results, it clearly has not been enough to rescue Prestige Consumer Healthcare's II. Quarter 2019 achievement, John Collins, Healthcare sector observer pointed out.

Within Major Pharmaceutical Preparations industry 5 other companies have achieved higher Net Income quarter on quarter growth. While Prestige Consumer Healthcare's Net Income growth quarter on quarter, overall rank is 568.


Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #6
Healthcare Sector #33
Overall #568
Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #6
Healthcare Sector #33
Overall #568
Net Income Q/Q Growth Statistics
High Average Low
411.21 % 51.64 % -90.45 %
(Mar 31 2014)  


PBH's II. Quarter Q/Q Net Income Comment
In the II. Quarter 2019 Prestige Consumer Healthcare Inc. reported drop in Net Income sequentially by -8.12% to $ 74.36 millions, from $ 80.93 millions released in the previous reporting period.

Those cyclical influence were not able to salvage the II. Quarter for the Prestige Consumer Healthcare Inc., John Collins, Healthcare sector observer pointed out, he mentioned little pessimism towards PBH's outlook.

Within Major Pharmaceutical Preparations industry 5 other companies have achieved higher Net Income quarter on quarter growth. While Prestige Consumer Healthcare's Net Income growth quarter on quarter, overall rank is 568.


Prestige Consumer Healthcare's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Sep 30 2018)
12 Months Ending
(Jun 30 2018)
12 Months Ending
(Mar 31 2018)
12 Months Ending
(Dec 31 2017)
12 Months Ending
(Sep 30 2017)
Cumulative Net Income 12 Months Ending $ 381.07 $ 386.74 $ 339.57 $ 497.31 $ 156.52
Y / Y Net Income Growth (TTM) 143.47 % 255.83 % 389.33 % 588.4 % 128.17 %
Year on Year Net Income Growth Overall Ranking # 114 # 144 # 91 # 8 # 62
Seqeuential Net Income Change (TTM) -1.47 % 13.89 % -31.72 % 217.74 % 44.01 %
Seq. Net Income Growth (TTM) Overall Ranking # 709 # 662 # 2173 # 9 # 103




Cumulative Net Income growth Comment
Assuming the Prestige Consumer Healthcare's fiscal year would have ended in Sep 30 2018, Prestige Consumer Healthcare would have reprted above average annual Net Income surge of 143.47% year on year, of $ 381 millions.
This marks a slow-down of the companys growth trends and from the 255.83% surge in Jun 30 2018.

Among companies within the Healthcare sector 8 other companies have achieved higher trailing twelve month Net Income growth. While Total ranking has impoved so far to 114, from total ranking in previous quarter at 144.

Net Income TTM Q/Q Growth Statistics
High Average Low
217.74 %
14.81 %
-31.73 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 7
Healthcare Sector # 9
Overall # 114

Net Income TTM Y/Y Growth Statistics
High Average Low
588.4 %
85.32 %
-38.51 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 7
Sector # 41
S&P 500 # 709
Cumulative Net Income growth Comment
Assuming the Prestige Consumer Healthcare's fiscal year would have ended in Sep 30 2018, Prestige Consumer Healthcare would have reprted above average annual Net Income surge of 143.47% year on year, of $ 381 millions.
This marks a slow-down of the companys growth trends and from the 255.83% surge in Jun 30 2018.

Among companies within the Healthcare sector 8 other companies have achieved higher trailing twelve month Net Income growth. While Total ranking has impoved so far to 114, from total ranking in previous quarter at 144.

Net Income TTM Q/Q Growth Statistics
High Average Low
217.74 %
14.81 %
-31.73 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 7
Healthcare Sector # 9
Overall # 114

Net Income TTM Y/Y Growth Statistics
High Average Low
588.4 %
85.32 %
-38.51 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 7
Sector # 41
S&P 500 # 709


You need to upgrade your Flash Player




Other Net Income Growth
Major Pharmaceutical Preparations Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
PBH's Net Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for PBH's Competitors
Net Income Growth for Prestige Consumer Healthcare's Suppliers
Net Income Growth for PBH's Customers

You may also want to know
PBH's Annual Growth Rates PBH's Profitability Ratios PBH's Asset Turnover Ratio PBH's Dividend Growth
PBH's Roe PBH's Valuation Ratios PBH's Financial Strength Ratios PBH's Dividend Payout Ratio
PBH's Roa PBH's Inventory Turnover Ratio PBH's Growth Rates PBH's Dividend Comparisons



Companies with similar Net Income surge for the quarter ending Sep 30 2018 within Healthcare SectorY/Y Change %Net Income for the quarter ending Sep 30 2018
Mednax, Inc. -0.46 %$ -0.463 millions
Intuitive Surgical Inc -1.92 %$ -1.916 millions
Fonar Corporation -2.37 %$ -2.369 millions
Shire Plc -2.47 %$ -2.469 millions
Psychemedics Corp -6.52 %$ -6.525 millions
Abbott Laboratories -6.63 %$ -6.633 millions
Haemonetics Corp -6.85 %$ -6.845 millions
Prestige Consumer Healthcare Inc. -7.08 %$ -7.080 millions
Amgen Inc. -8.02 %$ -8.016 millions
Eagle Pharmaceuticals, Inc. -9.01 %$ -9.014 millions
Lemaitre Vascular Inc -14.44 %$ -14.439 millions
Henry Schein Inc -15.88 %$ -15.881 millions
Standard Diversified Inc. -16.36 %$ -16.361 millions
Magellan Health Inc -18.33 %$ -18.327 millions
Conmed Corp -19.06 %$ -19.063 millions
Incyte Corp -19.08 %$ -19.077 millions
Lifepoint Health, Inc. -22.07 %$ -22.074 millions
Gilead Sciences Inc -22.60 %$ -22.603 millions
Ait Therapeutics, Inc. -37.57 %$ -37.572 millions
Emergent Biosolutions Inc. -37.57 %$ -37.573 millions
Natures Sunshine Products Inc -42.97 %$ -42.973 millions
Luna Innovations Inc -43.85 %$ -43.846 millions
Artemis Therapeutics, Inc. -46.27 %$ -46.269 millions
Shineco, Inc. -48.52 %$ -48.520 millions
Nuvasive Inc -52.02 %$ -52.017 millions
United Therapeutics Corp -61.45 %$ -61.455 millions
Rti Surgical, Inc. -82.25 %$ -82.249 millions
Diplomat Pharmacy, Inc. -82.41 %$ -82.414 millions
Surgery Partners, Inc. -85.91 %$ -85.915 millions
Encision Inc -89.41 %$ -89.410 millions


     
       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

AMPE's Profile

Stock Price

AMPE's Financials

Business Description

Fundamentals

Charts & Quotes

AMPE's News

Suppliers

AMPE's Competitors

Customers & Markets

Economic Indicators

AMPE's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Expectations

Management Effectivness

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2018 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071